Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | PPARG | P37231 | 7/20 | 0.38 |
| ▸ | PPARA | Q07869 | 7/20 | 0.38 |
| ▸ | PPARD | Q03181 | 3/20 | 0.38 |
| ▸ | DPP4 | P27487 | 1/20 | 0.37 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3024199 | 0.88 | NPC1 (0.39) | NPC1RAB9APPARGPPARAPPARD | |
| SCHEMBL27934025 | 0.88 | NPC1 (0.39) | NPC1RAB9APPARGPPARAPPARD | |
| SCHEMBL16798761 | 0.88 | NPC1 (0.39) | NPC1RAB9APPARGPPARAPPARD | |
| SCHEMBL28484186 | 0.82 | NPC1 (0.40) | NPC1RAB9APPARGPPARAPPARD | |
| SCHEMBL28700468 | 0.82 | DPP4 (0.40) | NPC1RAB9APPARGPPARAPPARD | |
| SCHEMBL29349976 | 0.82 | ALDH1A1 (0.40) | NPC1RAB9ADPP4LMNAHTT | |
| SCHEMBL2744761 | 0.82 | NPC1 (0.41) | NPC1RAB9APPARGPPARAPPARD | |
| SCHEMBL29726893 | 0.82 | DPP4 (0.40) | NPC1RAB9APPARGPPARAPPARD | |
| SCHEMBL2778024 | 0.82 | NPC1 (0.41) | NPC1RAB9APPARGPPARAPPARD | |
| SCHEMBL4667781 | 0.82 | NPSR1 (0.40) | NPC1RAB9APPARGPPARADPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100190645-A1 | SYNERGISTIC FUNGICIDAL ACTIVE COMPOUND COMBINATIONS COMPRISING FORMONONETIN | PLANT HEALTH CARE, INC. | 2010-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100190645-A1 | SYNERGISTIC FUNGICIDAL ACTIVE COMPOUND COMBINATIONS COMPRISING FORMONONETIN | CYP51A1, ERG28, CYP3A7 | NPC1 2029/4885RAB9A 1672/4885PPARG 3162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.